Perioperative considerations for the patient taking herbal medicines

Heart Disease

Volumn 3, Issue 2, 2001, Pages 87-96

  Sabar, R ^a   Kaye, A D ^a   Frost, E A M ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Anesthesia; Herbal supplements; Toxicity

Indexed keywords

ACETYLSALICYLIC ACID; ANESTHETIC AGENT; ATROPINE; COCAINE; CODEINE; CORTICOSTEROID; CYCLOSPORIN; DIGITALIS; DRUG; EPHEDRINE; GINKGO BILOBA EXTRACT; HEPARIN; HERBACEOUS AGENT; IPECAC; KAVA; NONSTEROID ANTIINFLAMMATORY AGENT; PHYSOSTIGMINE; SCOPOLAMINE; WARFARIN;

ALOE; ANESTHESIA; APHTHOUS ULCER; CARDIOVASCULAR DISEASE; CHRYSANTHEMUM; DEATH; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG LEGISLATION; DRUG SAFETY; ECHINACEA; EPHEDRA; FOOD AND DRUG ADMINISTRATION; GARLIC; GASTROINTESTINAL SYMPTOM; GINGER; GINSENG; HALITOSIS; HEART ARRHYTHMIA; HERBAL MEDICINE; HUMAN; HYPERICUM PERFORATUM; HYPOTENSION; LIVER TOXICITY; PERIOPERATIVE PERIOD; REVIEW; STROKE; TACHYPHYLAXIS; THROMBOCYTE DYSFUNCTION; TRADITIONAL MEDICINE; VERTIGO; XEROSTOMIA;

EID: 0035205997     PISSN: 1521737X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00132580-200103000-00006     Document Type: Review

References (110)

1. Herbal roulette
2. Unconventional medicine in the United States: Prevalence, costs and patterns of use
3. Trends in alternative medicine use in the United States, 1990-1997
4. Herbal medicine: Is it an alternative or an unknown? A brief review of popular herbals used by patients in a pain and symptom management practice setting
5. Herbs as medicines
6. Now in the HMO: Yoga teachers and naturopaths
7. The true nature of herbs
8. The US botanical market: An overview
9. Alternative medicine: What the data say about common herbal therapies
10. Structure stereochemistry of new sesquiterpene esters from E. purpurea
11. Echinacea root extracts for the prevention of upper respiratory tract infections: A double-blind, placebo-controlled, randomized trial
12. A randomized controlled trial of the effect of fluid extract of Echinacea purpurea on the incidence and severity of colds and respiratory infections
13. Benefit-risk assessment of the squeezed sap of the purple coneflower (E. purpurea) for long term oral immunostimulation
14. Herbal medicinals
15. Flavonoids, potent inhibitors of the human form of phenolsulfotransferase: Potential role in drug metabolism and chemoprevention
16. Flavonoids in grapefruit juice inhibit the in-vitro hepatic metabolism of 17 beta-estradiol
17. Allium sativum and Allium ursinum, part 2: Pharmacology and medicinal applications
18. Garlic for flavor, not cardioprotection
19. Can garlic reduce levels of serum lipids? A controlled clinical study
20. A mete-analysis of the effect of garlic on blood pressure
21. Garlic powder in the treatment of moderate hyperlipidemia: A controlled trial and meta-analysis
22. Effect of a garlic oil preparation on serum lipoproteins and cholesterol metabolism: A randomized controlled trial
23. The effect of essential oil of garlic on hyperlipidemia and platelet aggregation: An analysis of 308 cases
24. Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic consumption: A case report
25. Effect of garlic on human platelet aggregation in vitro
26. Vertigo-reducing effect of ginger root
27. The anti-motion sickness mechanism of ginger
28. Ginger treatment of hyperemesis gravidarum
29. A double-blind randomized controlled trial of ginger for the prevention of postoperative nausea and vomiting
30. The efficacy of ginger root in the prevention of postoperative nausea and vomiting after out patient gynecological laparoscopy
31. Ginger: Inhibition of thromboxane synthetase and stimulation of prostacyclin: Relevance for medicine and psychiatry
32. Medicinal plants rediscovered
33. A placebo controlled, double blind, randomized trial of an extract of Gingko biloba for dementia
34. Six-month double-blind randomized clinical trial of gingko biloba extract versus placebo in two parallel groups in patients suffering from peripheral arterial insufficiency
35. Demonstration of the efficacy of Gingko biloba special extract EGB 761 on intermittent claudication: A placebo controlled, double-blind multicenter trial
36. BN 52021 and related compounds: A new series of highly specific PAF-acether receptor antagonists isolated from gingko biloba
37. Anti-anaphylactic properties of BN 52021: A potent platelet activating factor antagonist
38. The nitric oxide scavenging properties of gingko biloba extract Egb761: Inhibitory effect on nitric oxide production in the macrophage cell line RAW 264.7
39. Gingko biloba extract (Egb 761): Inhibitory effect on nitric oxide production in macrophage cell line RAW 264.7
40. Spontaneous hyphema associated with ingestion of Gingko biloba extract
41. Spontaneous bilateral subdural hematomas associated with chronic Gingko biloba ingestion have also occurred
42. Gingko biloba
43. Subarachanoid hemorrhage associated with Gingko biloba
44. Occurrence of neurotoxic 4′ -o-methylpyridoxin in gingko biloba leaves, Gingko medications and Japanese Gingko food
45. Psychopharmaka
46. Pharmacokinetics of hypericin and pseudohypericin after local intake of the Hypericum perforatum extract LI160 in healthy volunteers
47. In vitro receptor binding and enzyme inhibition by Hypericum perforatum extract
48. Medicinal plants: A potential source of new psychotherapeutic drugs
49. Effect of Hypericum extract on the suppression of serotonin receptors
50. St. John's wort for depression- an overview and meta-analysis of randomized clinical trials
51. The effect of hypericum extract on cardiac conduction as seen in the electrocardiogram compared to that of imipramine
52. Evaluation of ergogenic properties of ginseng
53. Effects of ginsenosides on myocardial ischemia/reperfusion damage in open heart surgery patients
54. Pulmonary, protective and vasodilator effects of a standardized panax ginseng preparation following artificial gastric digestion
55. Effects of ginsenosides, lectins and Momordica charantia insulin like peptide on corticosterone production by isolated rat adrenal cells
56. Immunomodulatory effects of panax ginseng: CA Meyer in the mouse
57. Ginseng therapy in non-insulin dependent diabetic patients
58. Studies on the mechanism of hypoglycemic activity of ginsenoside-Rb2 in streptozotocin-diabetic rats
59. Isolation and hypoglycemic activity of panaxans I, J, K and L, glycans of panax ginseng roots
60. Isolation and hypoglycemic activity of panaxans Q, R, S, R and U: Glycans of panax ginseng roots
61. Isolation and hypoglycemic activity of panaxans A, B, C, D and E glycans of panax ginseng roots
62. Partial structure of panax A: A hypoglycemic glycan of panax ginseng roots
63. What pharmacists should know about ginseng
64. Adverse reactions to ginseng
65. Ginseng a cause of Steven-Johnson Syndrome
66. Ginseng and vaginal bleeding
67. Ginseng face cream and unexpected vaginal bleeding
68. Ginseng and mastalgia
69. A review of 12 commonly used medicinal herbs
70. Probable interactions between warfarin and ginseng
71. Antiplatelet components in panax ginseng
72. Phenelzine and the dream machine-ramblings and reflections
73. Interactions of ginseng with phenelzine
74. Herbal medicines in Hawaii from tradition to convention
75. Kava dermopathy
76. Some visual effects caused by the beverage kava
77. The antinociceptive actions of kava components in mice
78. Effects of kava on neuromuscular transmission and muscular contractility
79. [3H]-monoamine uptake inhibition properties of kava pyrones
80. Positive interaction of ethanol and kava resin in mice
81. Piper methysticum (kava kava)
82. Randomized double-blind, placebo-controlled trial of feverfew in migraine prevention
83. Herbal medicines in migraine prevention: Randomized double-blind, placebo-controlled crossover trial of a feverfew preparation
84. A bioassay of inhibition of serotonin release from bovine platelets
85. 5-Hydroxytryptamine in the pathophysiology of migraine
86. A platelet phospholipase inhibitor from the medicinal herb feverfew (Tanacatum parthenium)
87. Extract of feverfew inhibits prostaglandins biosynthesis
88. Drug information, US Pharmacopoeia. Feverfew
89. What pharmacists should know about feverfew
90. Extracts of feverfew may inhibit platelet behavior neutralization of sulfhydryl groups
91. The active principle in feverfew
92. Ephedrine therapy in asthmatic children. Clinical tolerance and absence of side effects
93. Ephedrine pharmacokinetics after ingestion of nutritional supplements containing ephedra sinica (ma huang)
94. Accidental shock during epidural anesthesia in a patient with NSAID-induced hyporeninemic hypoaldosteronism
95. Hemodynamic actions of Huatuo reconstruction pill on anesthetized animals
96. Rapidly progressive interstitial renal fibrosis in young women: Association with slimming regimen including Chinese herbs
97. Chinese herbal medicine induced acute renal failure
98. Identification of aristolochic acid in Chinese herbs
99. The tragic paradigm of Chinese herbs nephropathy
100. Chaparral ingestion: The broadening spectrum of liver injury caused by berbal medications
101. Chaparral-associated hepatotoxicity
102. Liver transplantation for severe acute liver failure after herbal medicine (Teucrium polium) administration